| scholarly article | Q13442814 |
| P50 | author | Jean-Martin Beaulieu | Q30513917 |
| P2093 | author name string | Matthieu J Guitton | |
| Camille Latapy | |||
| Véronique Rioux | |||
| P2860 | cites work | A beta-arrestin 2 signaling complex mediates lithium action on behavior | Q24306355 |
| An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior | Q24310712 | ||
| Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter | Q24310836 | ||
| Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis | Q24556648 | ||
| Cell signaling by receptor tyrosine kinases | Q24598357 | ||
| A molecular mechanism for the effect of lithium on development | Q24629067 | ||
| A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health | Q28118906 | ||
| Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation | Q28140761 | ||
| Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia | Q28254349 | ||
| Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter | Q28263277 | ||
| LTP inhibits LTD in the hippocampus via regulation of GSK3beta | Q28290606 | ||
| Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region | Q28297391 | ||
| The physiology, signaling, and pharmacology of dopamine receptors | Q28305030 | ||
| GSK-3beta is required for memory reconsolidation in adult brain | Q28473886 | ||
| Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo | Q28512114 | ||
| Synthesis of serotonin by a second tryptophan hydroxylase isoform | Q28513857 | ||
| Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex | Q28574586 | ||
| Decrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeks | Q28578836 | ||
| Serotonin receptor 1A knockout: an animal model of anxiety-related disorder | Q28592514 | ||
| Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice | Q29618044 | ||
| Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells | Q29618245 | ||
| Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress | Q29618764 | ||
| Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium | Q30362607 | ||
| Brain serotonin receptors and transporters: initiation vs. termination of escalated aggression | Q30453470 | ||
| Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation? | Q30475816 | ||
| Abnormalities in brain structure and behavior in GSK-3alpha mutant mice | Q30485018 | ||
| Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances | Q30495108 | ||
| Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia | Q31842937 | ||
| Cre/loxP recombination-activated neuronal markers in mouse neocortex and hippocampus | Q43916728 | ||
| Lithium chloride, administered chronically to rats, does not affect the fractional phosphorylation of brain cytosolic phospholipase A2, while reducing its net protein level | Q44237514 | ||
| The amyloid precursor protein protects PC12 cells against endoplasmic reticulum stress-induced apoptosis | Q44581792 | ||
| Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia | Q44743796 | ||
| Tryptophan hydroxylase-2 controls brain serotonin synthesis | Q44973406 | ||
| AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test | Q45021524 | ||
| A new optical parametric amplifier based on lithium thioindate used for sum frequency generation vibrational spectroscopic studies of the amide I mode of an interfacial model peptide | Q46359843 | ||
| Taste-dependent sociophobia: when food and company do not mix. | Q46596136 | ||
| Overview: a rare opportunity or just one less reason to be depressed | Q46842827 | ||
| Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. | Q47860639 | ||
| Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. | Q48433009 | ||
| Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs | Q48493255 | ||
| Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. | Q48556742 | ||
| Automated tests for measuring the effects of antidepressants in mice | Q48963867 | ||
| INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN THE INTACT RAT BRAIN BY IMIPRAMINE AND STRUCTURALLY RELATED COMPOUNDS. | Q51264563 | ||
| Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania. | Q53444102 | ||
| The effect of imipramine on central 5-hydroxytryptamine neurons | Q68725685 | ||
| Effect of chronic tricylic antidepressant treatment on the serotoninergic autoreceptor: a microiontophoretic study in the rat | Q71447450 | ||
| Peripherin-mediated death of motor neurons rescued by overexpression of neurofilament NF-H proteins | Q73138241 | ||
| Effects of centrally administered anxiolytic compounds in animal models of anxiety | Q33540480 | ||
| GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism. | Q33543082 | ||
| Tissue-specific analysis of glycogen synthase kinase-3α (GSK-3α) in glucose metabolism: effect of strain variation | Q33799189 | ||
| A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors | Q33953387 | ||
| Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors | Q34093012 | ||
| Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence | Q34192699 | ||
| Automated apparatus for quantitation of social approach behaviors in mice. | Q34345417 | ||
| Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression | Q34381106 | ||
| A functional alternative splicing mutation in human tryptophan hydroxylase-2. | Q34490921 | ||
| Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency | Q34587440 | ||
| Affective cognition and its disruption in mood disorders | Q34661207 | ||
| Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors | Q35505900 | ||
| Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons | Q35563894 | ||
| In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain | Q36002807 | ||
| The Mechanism of Action of Novel Antipsychotic Drugs | Q36515345 | ||
| Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice | Q36603189 | ||
| The Akt-GSK-3 signaling cascade in the actions of dopamine | Q36756203 | ||
| Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action | Q36959923 | ||
| Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation | Q37071768 | ||
| The role of GSK-3 in synaptic plasticity. | Q37098587 | ||
| Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain | Q37139160 | ||
| Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice | Q37257617 | ||
| Akt/GSK3 signaling in the action of psychotropic drugs | Q37301265 | ||
| Looking at lithium: molecular moods and complex behaviour | Q37327911 | ||
| Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade | Q37416273 | ||
| The importance of serotonin for orbitofrontal function | Q37847395 | ||
| Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis | Q37904401 | ||
| The size and burden of mental disorders and other disorders of the brain in Europe 2010. | Q37928182 | ||
| Cost of disorders of the brain in Europe 2010. | Q37933664 | ||
| Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice | Q38809906 | ||
| Functional significance of glycogen synthase kinase-3 regulation by serotonin | Q38887848 | ||
| A novel role of the WNT-dishevelled-GSK3β signaling cascade in the mouse nucleus accumbens in a social defeat model of depression | Q39288546 | ||
| Perspectives on the discovery of central monoaminergic neurotransmission | Q39508369 | ||
| Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium | Q40262756 | ||
| The dopamine hypothesis of schizophrenia: focus on the dopamine receptor | Q41076667 | ||
| Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice | Q42500923 | ||
| P433 | issue | 1601 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | serotonin | Q167934 |
| P1104 | number of pages | 15 | |
| P304 | page(s) | 2460-2474 | |
| P577 | publication date | 2012-09-01 | |
| P1433 | published in | Philosophical Transactions of the Royal Society B | Q2153239 |
| P1476 | title | Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviour | |
| P478 | volume | 367 |
| Q35653810 | Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer's pathologies |
| Q46820091 | Acute restraint stress impairs induction of long-term potentiation by activating GSK-3β. |
| Q97418693 | Advances toward precision medicine for bipolar disorder: mechanisms & molecules |
| Q39267279 | Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling. |
| Q37184659 | Characterization of maleimide-based glycogen synthase kinase-3 (GSK-3) inhibitors as stimulators of steroidogenesis |
| Q50486985 | Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease. |
| Q90282737 | Contribution of neuronal calcium sensor 1 (Ncs-1) to anxiolytic-like and social behavior mediated by valproate and Gsk3 inhibition |
| Q30833015 | Deletion of CTNNB1 in inhibitory circuitry contributes to autism-associated behavioral defects |
| Q28256783 | Dopamine receptors - IUPHAR Review 13 |
| Q47309989 | Effect of dietary palmitic and stearic acids on sucrose motivation and hypothalamic and striatal cell signals in the rat. |
| Q64085956 | Effects of treadmill exercise on the anxiety-like behavior through modulation of GSK3β/β-catenin signaling in the maternal separation rat pup |
| Q35990042 | FXR1P is a GSK3β substrate regulating mood and emotion processing |
| Q38155462 | Glycogen synthase kinase 3 beta (GSK3β) at the tip of neuronal development and regeneration |
| Q40362890 | Glycogen synthase kinase 3 beta alters anxiety-, depression-, and addiction-related behaviors and neuronal activity in the nucleus accumbens shell |
| Q91314984 | Glycogen synthase kinase 3 beta regulates ethanol consumption and is a risk factor for alcohol dependence |
| Q34554674 | Hypo-anxious phenotype of adolescent offspring prenatally exposed to LPS is associated with reduced mGluR5 expression in hippocampus |
| Q27497796 | IVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathology |
| Q30750632 | Identification of quantitative trait loci and candidate genes for an anxiolytic-like response to ethanol in BXD recombinant inbred strains |
| Q44273064 | Inositol hexakisphosphate kinase-1 regulates behavioral responses via GSK3 signaling pathways |
| Q48302767 | Linoleic acid derivative DCP-LA ameliorates stress-induced depression-related behavior by promoting cell surface 5-HT1A receptor translocation, stimulating serotonin release, and inactivating GSK-3β. |
| Q43084661 | Loss of GSK-3 Causes Abnormal Astrogenesis and Behavior in Mice |
| Q48581973 | Loss of glycogen synthase kinase 3 isoforms during murine oocyte growth induces offspring cardiac dysfunction. |
| Q54980050 | Mental Illnesses-Associated Fxr1 and Its Negative Regulator Gsk3β Are Modulators of Anxiety and Glutamatergic Neurotransmission. |
| Q26827615 | Molecular and genetic basis of depression |
| Q38122158 | Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication. |
| Q38149943 | New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease. |
| Q36332597 | Pathogenesis of depression: Insights from human and rodent studies |
| Q34503754 | Proline-, glutamic acid-, and leucine-rich protein 1 mediates estrogen rapid signaling and neuroprotection in the brain |
| Q41977968 | Regenerative potential of targeting glycogen synthase kinase-3 signaling in neural tissues |
| Q48072699 | Selective disruption of dopamine D2-receptors/beta-arrestin2 signaling by mood stabilizers |
| Q26765504 | Synaptic Wnt/GSK3β Signaling Hub in Autism |
| Q37613415 | The gender-specific association of rs334558 in GSK3β with major depressive disorder |
| Q43232499 | The neurobiology of depression--revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms |
| Q38101982 | Understanding the relationship between GSK-3 and Alzheimer's disease: a focus on how GSK-3 can modulate synaptic plasticity processes |
| Q28074740 | Wnt signaling networks in autism spectrum disorder and intellectual disability |
Search more.